Table 1.
Full and 1/2 site REs within1 Kb Flt1 motif::LUC | 1/2 site::LUC | Endogenous FLT1-T | ||||||||||||
Full sites | 1/2 sites | |||||||||||||
AIP | GADD45 | p21 | FLT1-T | 1/2 RE1 | 1/2 RE1 | 1/2 RE2 | ||||||||
p53 mutation | −ERα | +ERα | −ERα | +ERα | −ERα | +ERα | −ERα | +ERα | −ERα | +ERα | −ERα | −ERα | −ERβ | +ERβ |
WT | Yes | YES** | Yes | YES** | Yes | YES** | Yes | YES** | Yes | YES** | Yes | Yes | Low | YES** |
S121F | Yes | YES** | Yes | YES** | Slight | Slight | Yes | YES** | Yes | YES** | Yes | Yes | Slight | YES** |
A138V | Slight | YES** | Yes | YES** | Yes | YES** | No | YES** | Yes | YES** | Yes | Yes | No | YES** |
G279R | No | No | Slight | YES** | Yes | YES** | No | YES** | Slight | YES** | Yes | Yes | Slight | YES** |
R337H | Slight | YES** | Yes | YES** | Yes | YES** | No | YES** | Yes | YES** | Yes | Yes | Low | YES** |
E285K | No | No | Yes | YES** | No | No | No | No | Slight | Slight | Yes | No | No | No |
R337C | No | No | Slight | YES** | Yes | YES** | No | No | No | No | No | No | No | No |
T125R | No | No | Yes | Yes | Slight | Yes | No | No | Yes | Slight | Yes | No | No | No |
Y220C | No | No | No | No | No | No | No | Slight | No | Slight | Slight | No | No | Low |
M237I | No | No | No | Yes | No | No | No | No | Slight | Slight | Slight | No | Slight | No |
YES**, transactivation by WT or mutant p53 is enhanced by ERα or ERβ.
*R175H, G245 and G279E were also examined (Fig. 1B) but exhibited no transactivation under any condition.